Featured Content
Data Ecosystem
Technology Products
Topic

Public Health

Page:
1 2

How Amgen & HealthVerity found treatment gaps in high-risk diabetes care

Amgen’s new retrospective study, VESALIUS-REAL, examines how lipid-lowering therapy (LLT) is being used in clinical practice for patients with high-risk diabetes.1 The study draws on Verified de-identified medical and pharmacy claims from 2016 to 202...

Contact us